E8L, His, Monkeypox virus
E8L, His, Monkeypox Virus

E8L, His, Monkeypox virus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

E8L, His, Monkeypox virus

E8L is an important protein that mediates the invasion of monkeypox virus into host cells. In the process of invading and completing replication, E8L acts as a surface-binding protein of mature virion and can bind to chondroitin sulfate on the cell surface, so that the virus can attach to target cells.
Z05976
¥63,425.00

Ask us a question
Product Introduction
Species Monkeypox virus
Protein Construction
His E8L (Met1-Thr275)
Accession # QJQ40248.1
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System E.coli
Theoretical Molecular Weight 32.92 kDa
Apparent Molecular Weight The protein has a predicted MW of 32.92 kDa. The protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS, 200mM L-arginine (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • E8L, His, Monkeypox Virus
    • E8L, His, Monkeypox Virus

    E8L, His, Monkeypox virus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background E8L is an important protein that mediates the invasion of monkeypox virus into host cells. In the process of invading and completing replication, E8L acts as a surface-binding protein of mature virion and can bind to chondroitin sulfate on the cell surface, so that the virus can attach to target cells.
Synonyms Cell surface-binding protein; Carbonic anhydrase homolog

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.